UK markets closed
NIKKEI 225
38,202.37 -632.73 (-1.63%) HANG SENG
18,313.86 -165.51 (-0.90%) CRUDE OIL
78.73 +0.35 (+0.45%) GOLD FUTURES
2,322.40 -1.80 (-0.08%) DOW
38,955.91 +71.65 (+0.18%) Bitcoin GBP
50,039.75 -699.79 (-1.38%)
Rigel Pharmaceuticals, Inc. (RIGL)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
As of 01:29PM EDT. Market open.
Currency in USD
Valuation measures4
| Market cap (intra-day) | 209.61M |
| Enterprise value | 213.25M |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | 1.78 |
| Price/book (mrq) | N/A |
| Enterprise value/revenue | 1.82 |
| Enterprise value/EBITDA | -12.56 |
Trading information
Stock price history
| Beta (5Y monthly) | N/A |
| 52-week change 3 | 0.00% |
| S&P500 52-week change 3 | 25.38% |
| 52-week high 3 | 1.9600 |
| 52-week low 3 | 0.7100 |
| 50-day moving average 3 | 1.3108 |
| 200-day moving average 3 | 1.1790 |
Share statistics
| Avg vol (3-month) 3 | 1.5M |
| Avg vol (10-day) 3 | 1.69M |
| Shares outstanding 5 | 175.4M |
| Implied shares outstanding 6 | 175.4M |
| Float 8 | 146.96M |
| % held by insiders 1 | 2.11% |
| % held by institutions 1 | 61.24% |
| Shares short (15 Apr 2024) 4 | 5.17M |
| Short ratio (15 Apr 2024) 4 | 3.31 |
| Short % of float (15 Apr 2024) 4 | 3.01% |
| Short % of shares outstanding (15 Apr 2024) 4 | 2.95% |
| Shares short (prior month 15 Mar 2024) 4 | 4.94M |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | 1:9 |
| Last split date 3 | 25 Jun 2003 |
Financial highlights
Fiscal year
| Fiscal year ends | 31 Dec 2023 |
| Most-recent quarter (mrq) | 31 Mar 2024 |
Profitability
| Profit margin | -16.61% |
| Operating margin (ttm) | -23.59% |
Management effectiveness
| Return on assets (ttm) | N/A |
| Return on equity (ttm) | N/A |
Income statement
| Revenue (ttm) | 119.25M |
| Revenue per share (ttm) | 0.68 |
| Quarterly revenue growth (yoy) | 13.30% |
| Gross profit (ttm) | N/A |
| EBITDA | -14.64M |
| Net income avi to common (ttm) | -19.8M |
| Diluted EPS (ttm) | -0.1400 |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | N/A |
| Total cash per share (mrq) | N/A |
| Total debt (mrq) | N/A |
| Total debt/equity (mrq) | N/A |
| Current ratio (mrq) | N/A |
| Book value per share (mrq) | -0.16 |
Cash flow statement
| Operating cash flow (ttm) | N/A |
| Levered free cash flow (ttm) | N/A |
© 2024 Yahoo. All rights reserved.